Till Milde
Impact in
Papers in
-
- Histone Deacetylase Inhibitors Research 20
- Protein Degradation and Inhibitors 14
- Chromatin Remodeling and Cancer 5
- Ubiquitin and proteasome pathways 4
- Epigenetics and DNA Methylation 3
- Genetics 34
- Glioma Diagnosis and Treatment 34
- Co-authors
- Olaf Witt (47 shared papers)Ina Oehme (25 shared papers)Hedwig E. Deubzer (14 shared papers)Stefan M. Pfister (31 shared papers)Marco Lodrini (10 shared papers)Shahin Rafii (5 shared papers)Nicholas W. Gale (3 shared papers)George D. Yancopoulos (3 shared papers)
- Journals
- Neuro-Oncology (11 papers)Journal of Neuro-Oncology (6 papers)Cancers (4 papers)Journal of Clinical Investigation (4 papers)Brain Pathology (3 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Till Milde
69 papers receiving 3.9k citations
Till Milde's Hit Papers
Peers
Comparison fields: 5 of 113
- Genetics 657
- Oncology 1.2k
- Molecular Biology 2.4k
- Cancer Research 468
- Neurology 439
Countries citing papers authored by Till Milde
This map shows the geographic impact of Till Milde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Till Milde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Till Milde more than expected).
Fields of papers citing papers by Till Milde
This network shows the impact of papers produced by Till Milde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Till Milde. The network helps show where Till Milde may publish in the future.
Co-authors
The 25 scholars most cited alongside Till Milde, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | HDAC family: What are the cancer relevant targets? Hit paper breakdown → | 2008 | 880 |
| 2 | CD133 expression is not restricted to stem cells, and both CD133+ and CD133– metastatic colon cancer cells initiate tumors Hit paper breakdown → | 2008 | 730 |
| 3 | 2010 | 265 | |
| 4 | 2013 | 166 | |
| 5 | 2010 | 159 | |
| 6 | 2010 | 149 | |
| 7 | 2015 | 144 | |
| 8 | 2019 | 88 | |
| 9 | 2012 | 85 | |
| 10 | 2006 | 81 | |
| 11 | 2013 | 76 | |
| 12 | 2020 | 69 | |
| 13 | 2009 | 65 | |
| 14 | 2021 | 64 | |
| 15 | 2015 | 58 | |
| 16 | 2011 | 58 | |
| 17 | 2018 | 58 | |
| 18 | 2011 | 56 | |
| 19 | 2009 | 54 | |
| 20 | 2017 | 44 |
About Till Milde
Till Milde is a scholar working on Molecular Biology, Genetics, Neurology, Oncology and Cancer Research, having authored 74 papers that have together received 3.9k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (34 papers), Histone Deacetylase Inhibitors Research (20 papers), Neuroblastoma Research and Treatments (16 papers), Protein Degradation and Inhibitors (14 papers), Chromatin Remodeling and Cancer (5 papers), Ubiquitin and proteasome pathways (4 papers), Epigenetics and DNA Methylation (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Genetics (657 citations), Oncology (1.2k citations), Molecular Biology (2.4k citations), Cancer Research (468 citations) and Neurology (439 citations). Till Milde has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Olaf Witt, Ina Oehme, Hedwig E. Deubzer, Stefan M. Pfister, Marco Lodrini, Shahin Rafii, Nicholas W. Gale, George D. Yancopoulos, Muhamed Baljević and Andrey Korshunov. Their work appears in journals such as Neuro-Oncology, Journal of Neuro-Oncology, Cancers, Journal of Clinical Investigation and Brain Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.